Clinical trials recruiting in Fuchu-shi, Japan

Phase breakdown

Conditions recruiting in Fuchu-shi, Japan

Recruiting trials in Fuchu-shi, Japan

• A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
  NCT05995353 · Phase: Phase 3 · Ages: 2 Years to 17 Years · Sex: All (male and female)
• An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
  NCT05835310 · Phase: Phase 3 · Ages: 5 Years to 17 Years · Sex: All (male and female)
• Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease
  NCT06332534 · Phase: Phase 3 · Ages: 2 Years to 17 Years · Sex: All (male and female)
• cOncomitant Left Atrial aPpendage Closure and Pulsed Field ablaTION-Asia
  NCT06686485 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Fuchu-shi, Japan?

4 recruiting trials have at least one study site in Fuchu-shi, Japan.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.